Publications by authors named "Hu-Cheng Ma"

Claim this Profile
M
Mesenchymal stem cells increase heme oxygenase 1-activated autophagy in treatment of acute liver failure.
Yue Wang, Jing-Lin Wang, Hu-Cheng Ma, Zhen-Ting Tang, Hao-Ran Ding

Biochem Biophys Res Commun· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PARP-1 promotes tumor recurrence after warm ischemic liver graft transplantation via neutrophil recruitment and polarization.
Shuai Wang, Fa-Ji Yang, Xun Wang, Yuan Zhou, Bo Dai, Hu-Cheng Ma

Oncotarget· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesenchymal stem cells increase expression of heme oxygenase-1 leading to anti-inflammatory activity in treatment of acute liver failure.
Zhi-Heng Zhang, Wei Zhu, Hao-Zhen Ren, Xin Zhao, Shuai Wang, Hu-Cheng Ma

Stem Cell Res Ther· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Puerarin protects against CCl4-induced liver fibrosis in mice: possible role of PARP-1 inhibition.
Shuai Wang, Xiao-Lei Shi, Min Feng, Xun Wang, Zhi-Heng Zhang, Hu-Cheng Ma

Int Immunopharmacol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-10 Contributes to Therapeutic Effect of Mesenchymal Stem Cells for Acute Liver Failure via Signal Transducer and Activator of Transcription 3 Signaling Pathway.
Hu-Cheng Ma, Xin Wang, Min-Na Wu, Xin Zhao, Xian-Wen Yuan

Chin Med J (Engl)· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted migration of mesenchymal stem cells modified with CXCR4 to acute failing liver improves liver regeneration.
Hu-Cheng Ma, Xiao-Lei Shi, Hao-Zhen Ren, Xian-Wen Yuan, Yi-Tao Ding

World J Gastroenterol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Administration of IL-1Ra chitosan nanoparticles enhances the therapeutic efficacy of mesenchymal stem cell transplantation in acute liver failure.
Jiang-qiang Xiao, Xiao-lei Shi, Hu-cheng Ma, Jia-jun Tan, Lin-zhang

Arch Med Res· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis